Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Grifols
Biotech
GigaGen garners up to $135M BARDA bucks to beat botulism
The California-based biotech will work to clinically develop and manufacture antibodies that target seven botulinum toxin variants.
Darren Incorvaia
Oct 3, 2024 8:00am
Araclon vaccine appears to slow Alzheimer's in phase 2 analysis
Oct 25, 2023 6:50am
BD continues pharmacy tech shopping spree with MedKeeper buy
Jul 28, 2022 11:00am
Grifols ponies up $80M for polyclonal antibody biotech GigaGen
Mar 10, 2021 9:50am
Grifols buys antibiotic assets from bankrupt partner Aradigm
Feb 24, 2020 8:57am
J&J launches biologic protein spray for sealing surgical bleeds
Dec 3, 2019 11:30am
